Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FA3VU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,220
Award facts
- Contract value 100% obligated
- $14,219.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors valued at $14,219.86 with a firm fixed price structure. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a for-profit organization registered in the System for Award Management, the company has demonstrated capability to meet federal procurement requirements through open competition, with its federal contract awards ranging from small-value transactions to substantial orders exceeding $45,000. The Dupixent delivery in this award supports military and veteran healthcare systems' immunology and dermatology treatment needs.
Quick answers
Who was awarded contract SPE2DB25FA3VU?
SPE2DB25FA3VU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FA3VU worth?
The government has obligated $14,220 on SPE2DB25FA3VU.
Is contract SPE2DB25FA3VU an order under another contract?
Yes. SPE2DB25FA3VU is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FA3VU competed?
The extent of competition for SPE2DB25FA3VU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award